Loading...
The proposal to the WTO for a new patent waiver on Covid-19 vaccines and pharmaceuticals : Is It necessary under TRIPS?
Khorseduzzaman, MD Islam, M Rafiqul
Khorseduzzaman, MD
Islam, M Rafiqul
Citations
Altmetric:
Abstract
This article is based in the context of a patent waiver proposal for Covid-19 vaccines, medicines, diagnostics and medical technologies placed at the WTO TRIPS Council. Most developed countries oppose it, and it is highly unlikely that WTO Members will be able to reach a consensus on this issue. But finding a legal answer on the necessity of such a waiver is the main objective of this academic research. It examines the existing flexibilities under TRIPS, appraises the recent developments and national measures taken by both developed and developing countries to access Covid-19 pharmaceuticals. It concludes that the existing parameters of intellectual property rights flexibilities under TRIPS may be inadequate for equitable access to Covid-19 life-saving medicines. Even if WTO Members disapprove of a new patent waiver, further clarification of some TRIPS flexibilities is essential for quick, global and equal access to these Covid-19 pharmaceuticals.
Keywords
access to medicines, coronavirus, pandemics, patents, pharmaceuticals, TRIPS, vaccines, waivers
Date
2021
Type
Journal article
Journal
European Intellectual Property Review
Book
Volume
43
Issue
10
Page Range
645-653
Article Number
ACU Department
Thomas More Law School
Faculty of Law and Business
Faculty of Law and Business
Collections
Relation URI
DOI
Source URL
Event URL
Open Access Status
License
All rights reserved
File Access
Controlled